Delving into the Latest Updates on Etinpro (Beijing) Co. Ltd. with Synapse

Overview

主要目的：比对试验药物利拉鲁肽注射液与对照药物诺和力®在中国健康男性受试者中单次皮下注射给药的主要药代动力学（PK）参数，评价两药物的生物等效性。次要目的：评价试验药物利拉鲁肽注射液与对照药物诺和力®在中国健康男性受试者中单次皮下注射给药的安全性。

[Translation]

Primary objective: To compare the main pharmacokinetic (PK) parameters of the experimental drug liraglutide injection and the control drug Victoza® in healthy Chinese male subjects after a single subcutaneous injection, and to evaluate the bioequivalence of the two drugs. Secondary objective: To evaluate the safety of the experimental drug liraglutide injection and the control drug Victoza® in healthy Chinese male subjects after a single subcutaneous injection.

Start Date-

Sponsor / Collaborator

Hangzhou Sciwind Biosciences Co., Ltd.Startup

[+1]

100 Clinical Results associated with Etinpro (Beijing) Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Etinpro (Beijing) Co. Ltd.

Login to view more data

100 Deals associated with Etinpro (Beijing) Co. Ltd.

Login to view more data

100 Translational Medicine associated with Etinpro (Beijing) Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data